SEROQUEL - 0310-0282-94 - (Quetiapine fumarate)

Alphabetical Index


Drug Information of SEROQUEL

Product NDC: 0310-0282
Proprietary Name: SEROQUEL
Non Proprietary Name: Quetiapine fumarate
Active Ingredient(s): 200    mg/1 & nbsp;   Quetiapine fumarate
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of SEROQUEL

Product NDC: 0310-0282
Labeler Name: AstraZeneca Pharmaceuticals LP
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022047
Marketing Category: NDA
Start Marketing Date: 20070716

Package Information of SEROQUEL

Package NDC: 0310-0282-94
Package Description: 4 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-94)

NDC Information of SEROQUEL

NDC Code 0310-0282-94
Proprietary Name SEROQUEL
Package Description 4 TABLET, EXTENDED RELEASE in 1 BOTTLE (0310-0282-94)
Product NDC 0310-0282
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Quetiapine fumarate
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20070716
Marketing Category Name NDA
Labeler Name AstraZeneca Pharmaceuticals LP
Substance Name QUETIAPINE FUMARATE
Strength Number 200
Strength Unit mg/1
Pharmaceutical Classes Atypical Antipsychotic [EPC]

Complete Information of SEROQUEL


General Information